Second malignancies from adjuvant chemotherapy? Too soon to tell.
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000009:adverse effects; D005260:Female; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D008558:Melphalan / Q000009:adverse effects; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D051381:Rats
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D008558:Melphalan